Each of our systems have unique energy ranges, applicators, and treatment capabilities. Learn which of our radiotherapy systems is right for you and your patients by watching the video below. Our Chief Science Officer, Amanda Tulk, outlines the key differences of each...
In the study, Pan02: A murine model of pancreatic cancer, Labcorp researcher Sumithra Urs, PhD investigated tumor responses to radiotherapy, immunomodulation, and combination therapy. See more below and the original research here.
In this video, Prof. Dr. med Bernadette Eberlein presents on using Radiotherapy for Peyronie Disease. This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See the full recording at https://xstrahl.com/symposia-session-2/...
Sheri Barnes of Labcorp presented as part of an AACR webinar series on her research, Focal Radiation Enhances Anti-Tumor Activity and immunomodulation of checkpoint blockade in the GL261-luc Orthotopic Murine Glioma Model. https://youtu.be/AxFF_vBdk4U
Xstrahl recently installed its 100th 3D cabinet irradiator at Duke University, the latest institution to use SARRP for translational radiation research. To mark this important milestone, we wanted to spotlight Duke’s research interests along with highlights from a few...
In this publication, Analysis of clonogenic growth in vitro, researchers expanded on the clonogenic assay protocol developed by Puck & Marcus. Researchers expanded the protocol to examine clonogenic survival of cancer and nonmalignant cells in response to radio-...
Published by VetSurgeon.org Yorkshire-based Paragon Referrals has launched a superficial radiation therapy (SRT) service for pets, the first of its kind in the country. The service uses an Xstrahl 100 superficial radiotherapy system, a £150,000 piece of equipment...
This video provides a brief overview of our clinical systems, featuring the Xstrahl 200 installed at the Federovich Clinical Sanatorium in Tashkent, Uzbekistan. Learn about some of the key features of Xstrahl's superficial radiotherapy systems....
Learn about RADiant from Xstrahl's CEO, Adrian Treverton. RADiant is a portable and easy-to-use system that can treat a range of skin conditions, including skin cancer. https://vimeo.com/711329383
Contact Us